OMICS International Organises 3000+ Global Conferenceseries Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
For more Conferences visit


Wolfgang Sadee

Wolfgang Sadee

Felts Mercer Professor of Medicine and Chair, Pharmacology
Director, Program in Pharmacogenomics
The Ohio State University


Dr. Wolfgang Sadee, Dr. Rer. Nat. Co-founded AIKO Biotechnology, Inc. in 2006 and serves as its Chief Scientific Officer. Dr. Sadee is responsible for the scientific direction of AIKO. He also serves as Felts Mercer Professor of Medicine and Pharmacology, Chair of Department of Pharmacology and Director of Program in Pharmacogenomics at College of Medicine of The Ohio State University, Columbus OH. He also teaches pharmacogenomics, pharmacology, and history of health sciences. He served at USC in Los Angeles as Assistant Professor of Pharmacy and Medicine from 1981 to 1983. He then joined University of California San Francisco (UCSF) and served as its Professor of Biopharmaceutical Sciences and Pharmaceutical Chemistry until 2002. Dr. Sadee\\\'s research focuses on the genetic basis of variable drug responses in CNS and cardiovascular diseases, including addiction, and in cancer chemotherapy. He also studies signal transduction of G protein coupled receptors and pursues drug discovery in the treatment of addiction. He has served as founding editor of Pharmaceutical Research and the open access, on-line AAPS Journal. Dr. Sadee has published over 300 research papers and monographs. He has received the first AAPS Research Achievement Award in Biotechnology, the Paul Dawson Award in Biotechnology from AACP, and the 2001 Distinguished Pharmaceutical Scientist Award from AAPS. He studied Pharmacy and received his doctorate in Pharmaceutical Chemistry at the FU Berlin in 1968 and has two Post-doctoral Positions at UCSF and the FU Berlin.


The use of genetic and genomic information in drug discovery, development, and therapy. His research spans the areas of molecular pharmacology, pharmacogenetics, and bioinformatics.